Pharmazac announces Nitastin
November 2, 2023
Member of Hellenic Association of Pharmaceutical Companies
November 2, 2023Pharmazac announces Rosuvastatin
Pharmazac launched the first Rosuvastatin generic in the Greek Pharmaceutical Market.
Rosuvastatin is available in two forms of 14 and 30 film coated tablets and composition of 5mg, 10mg, 20mg and 40mg.
Rosuvastain/Pharmazac is an HMG – CoA reductase inhibitor indicated for patients with primary hypercholesterolaemia or mixed dyslipidemia.
